Limina. Research

Reprogramming the trajectory of human aging

Limina Research is a regenerative medicine company building a multi-modal platform to intervene in the core mechanisms of human aging. Our programs span engineered cell therapies and epigenetic reprogramming, targeting senescence, tissue degeneration, and the loss of regenerative capacity at their molecular origins.

Cell Engineering Epigenetic Reprogramming iPSC-Derived Therapeutics Longevity Science
Inquiries
Beau Gaddis
Founder & CEO
Julian Jacobs
Founder & CFO